In vivo survival of red blood cells processed by a bubble or membrane oxygenator during cardiopulmonary bypass surgery
- PMID: 15227369
- PMCID: PMC324635
In vivo survival of red blood cells processed by a bubble or membrane oxygenator during cardiopulmonary bypass surgery
Abstract
A dual radioisotope labeling technique was utilized to assess red cell survival differences between cells processed by either a bubble oxygenator (eight patients) or membrane oxygenator (eight patients) in 16 patients undergoing cardiopulmonary bypass surgery. Cells processed by a bubble oxygenator consistently had a shortened survival. The 30-minute recovery of cells was not significantly different between oxygenators in contradiction to some previous studies using plasma hemoglobin as an indicator of hemolysis. The results of this investigation confirm previous studies that a membrane oxygenator provides a survival advantage to red cells during cardiopulmonary bypass surgery.
Similar articles
-
Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.J Thorac Cardiovasc Surg. 1985 Jun;89(6):888-99. J Thorac Cardiovasc Surg. 1985. PMID: 3158783 Clinical Trial.
-
Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation.J Thorac Cardiovasc Surg. 1992 Jan;103(1):78-86. J Thorac Cardiovasc Surg. 1992. PMID: 1728718
-
Membrane and bubble oxygenator: a clinical comparison in patients undergoing aortocoronary bypass procedures.Herz. 1979 Feb;4(1):56-62. Herz. 1979. PMID: 108187 Clinical Trial.
-
Membrane versus bubble oxygenator for cardiac operations. A prospective randomized study.J Thorac Cardiovasc Surg. 1980 Jul;80(1):111-22. J Thorac Cardiovasc Surg. 1980. PMID: 6966720 Clinical Trial.
-
Development of the oxygenator: past, present, and future.J Artif Organs. 2004;7(3):111-20. doi: 10.1007/s10047-004-0268-6. J Artif Organs. 2004. PMID: 15558331 Review.
References
LinkOut - more resources
Full Text Sources